E47 modulates hepatic glucocorticoid action
Glucocorticoids (GCs) are widely used anti-inflammatory drugs; however, long-term treatment causes metabolic side effects. Here, the authors show that E47 is a modulator of glucocorticoid receptor activity for a subset of target genes in mouse liver, and that loss of E47 protects mice from hyperglyc...
Saved in:
Main Authors: | M. Charlotte Hemmer, Michael Wierer, Kristina Schachtrup, Michael Downes, Norbert Hübner, Ronald M. Evans, N. Henriette Uhlenhaut |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/c66a0d65c60642e39dc4efc1ae62484e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chronic glucocorticoid treatment induces hepatic lipid accumulation and hyperinsulinaemia in part through actions on AgRP neurons
by: Erika Harno, et al.
Published: (2021) -
Modulation by Ozone of Glucocorticoid-Regulating Factors in the Lungs in Relation to Stress Axis Reactivity
by: Jith Thomas, et al.
Published: (2021) -
Impact of cadmium exposure during pregnancy on hepatic glucocorticoid receptor methylation and expression in rat fetus.
by: Paula Castillo, et al.
Published: (2012) -
TAZ inhibits glucocorticoid receptor and coordinates hepatic glucose homeostasis in normal physiological states
by: Simiao Xu, et al.
Published: (2021) -
Dietary essential amino acids restore liver metabolism in ovariectomized mice via hepatic estrogen receptor α
by: Sara Della Torre, et al.
Published: (2021)